logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Oops, what about ethics?

Oladimeji O, Isaakidis P, Zachariah R, Hinderaker SG, Koghali M,  et al.
2013-09-21 • Public Health Action
2013-09-21 • Public Health Action
Ethics approval of research studies is essential for the protection and rights of study subjects, whether this is for prospective research or record reviews. This article shares a painfu...
Journal Article
|
Research

Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria

Avong YK, Isaakidis P, Hinderaker SG, Van der Bergh R, Ali E,  et al.
2015-03-17 • PLOS One
2015-03-17 • PLOS One
Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings...
Journal Article
|
Research

Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria

Oladimeji O, Isaakidis P, Obasanya OJ, Eltayeb O, Khogali MA,  et al.
2014-04-10 • PLOS One
2014-04-10 • PLOS One
Nigeria is faced with a high burden of Human Immunodeficiency Virus (HIV) infection and multidrug-resistant tuberculosis (MDR-TB). Treatment outcomes among MDR-TB patients registered acr...